The ICH Guidelines (International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use) are a set of standards and recommendations designed to ensure the quality, safety, and efficacy of medicines, including aspects of pharmacovigilance.
There are six guidelines distributed as follows:
Plans ensure that the benefits of a medicine outweigh the associated risks, keeping patient safety as a priority.
They allow for constant monitoring of the medicine's safety, identifying and managing adverse effects throughout its lifecycle.
They facilitate effective risk communication to healthcare professionals and patients, improving informed decision-making.
They ensure compliance with national and international regulations, maintaining high standards in the pharmaceutical industry.
They promote collaboration among healthcare professionals, regulators, and the pharmaceutical industry for more effective and coordinated risk management.
This Pharmacovigilance site does not collect Adverse Drug Reaction Reports.
If you wish to report an adverse effect or technical complaint regarding a pharmaceutical product, please contact your healthcare provider and/or the Health Authorities in your respective country.